About Nav Businesses Nav Investor Relations Products media
Media Room
Home > Media Room > News Releases

News Releases

Archives: Search / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004 / 2003 / 2002

Feb 04, 2010
Mylan Confirms First-to-File Patent Challenge Relating to Caduet®
Expects to qualify for 180 days of marketing exclusivity for multiple strengths
Feb 02, 2010
Mylan Schedules Fourth Quarter 2009 Financial Results Conference Call and Live Webcast
Jan 29, 2010
Mylan Receives Approval for Generic Version of GoLytely®
Jan 20, 2010
Mylan Declares Quarterly Preferred Stock Dividend
Jan 11, 2010
Mylan Confirms First-to-File Patent Challenge Relating to Sleep-Disorder Drug Nuvigil®
Expects to qualify for 180 days of marketing exclusivity for 50 mg, 150 mg and 250 mg strengths
 

The news releases on this page are included for historical puposes only. The information contained in each press release speaks only as of the date thereof and assumes no duty to update such information beyond the dates thereof.


 Email Page    Print